Peter J. Kushner, Ph.D.
Peter is the founding Chairman and CSO of Olema. He is an Emeritus Professor in the Department of Medicine, Division of Endocrinology, University of California, San Francisco. He has studied the mechanisms and functions of the estrogen receptors and has published some of the most highly cited papers in the field, including ones showing the molecular mechanism of action of the breast cancer drug tamoxifen.
Along with other colleagues from UCSF, he was a founder of Serra Pharmaceuticals, a California biotechnology company which was purchased by KaroBio AB, in Stockholm, Sweden. He served on the Board of Directors of KaroBio from 1996 to 2002.